" ..... Rasagiline (Azilect) is a potent, selective, irreversible monoamine oxidase ( MAO ) type-B inhibitor. It is a useful agent in the symptomatic treatment of Parkinson's disease . Rasagiline and its analogues are under investigation for Alzheimer's disease . Both rasagiline and its aminoindan metabolite exert a neuroprotective effect by increasing brain-derived neurotrophic factor ( BDNF ) in the hippocampus and striatum; they may enhance memory and learning . Rasagiline may also improve mood, motivati
Links to rasagiline.com (12)
biopsychiatry.comThe Good Drug Guide : new mood-brighteners and antidepressants